|
BAT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.91249999995191E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.198600E-03 |
| Normal-vs-Stage2 |
1.780640E-04 |
| Normal-vs-Stage3 |
8.05159999783811E-08 |
| Normal-vs-Stage4 |
1.67860999999991E-05 |
| Stage1-vs-Stage2 |
5.625900E-02 |
| Stage1-vs-Stage3 |
1.264930E-03 |
| Stage1-vs-Stage4 |
2.482000E-02 |
| Stage2-vs-Stage3 |
7.986000E-01 |
| Stage2-vs-Stage4 |
9.777200E-01 |
| Stage3-vs-Stage4 |
7.358600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.21899999988773E-07 |
| Normal-vs-AfricanAmerican |
3.572200E-01 |
| Normal-vs-Asian |
3.544800E-01 |
| Caucasian-vs-AfricanAmerican |
7.784900E-03 |
| Caucasian-vs-Asian |
4.133200E-01 |
| AfricanAmerican-vs-Asian |
6.992200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.6362000027369E-08 |
| Normal-vs-Female |
1.507780E-02 |
| Male-vs-Female |
7.81630000000755E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.953550E-02 |
| Normal-vs-Age(41-60Yrs) |
2.582300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.80919999995355E-06 |
| Normal-vs-Age(81-100Yrs) |
1.992560E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.548400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.732800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.030400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.700580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.927800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.361800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.897850E-02 |
| Normal-vs-Grade 2 |
8.953100E-04 |
| Normal-vs-Grade 3 |
6.02769999469288E-08 |
| Normal-vs-Grade 4 |
3.34680000046994E-07 |
| Grade 1-vs-Grade 2 |
5.92569999999792E-05 |
| Grade 1-vs-Grade 3 |
2.86119999914902E-08 |
| Grade 1-vs-Grade 4 |
8.98709995311719E-09 |
| Grade 2-vs-Grade 3 |
1.705770E-02 |
| Grade 2-vs-Grade 4 |
6.855900E-03 |
| Grade 3-vs-Grade 4 |
3.975800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.158900E-04 |
| Normal-vs-ccB subtype |
1.67689999996945E-06 |
| ccA subtype-vs-ccB subtype |
2.624000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64528999999636E-05 |
| Normal-vs-N1 |
5.444000E-02 |
| N0-vs-N1 |
8.785400E-01 |
|
|
